Comprehensive molecular testing in patients with high functioning autism spectrum disorder.
暂无分享,去创建一个
Á. Carracedo | G. Aznar Laín | M. Milá | I. Quintela | J. Amigo | L. Rodriguez-Revenga | I. Madrigal | Olga Puig Navarro | R. Calvo Escalona | M. Linder-Lucht | M. I. Álvarez-Mora | Dei Martinez-Elurbe | L. Rodríguez-Revenga | Montserrat Milà | R. Calvo Escalona | Jorge Amigo | Dei Martinez-Elurbe | Michaela Linder-Lucht | Gemma Aznar Lain | Angel Carracedo | Ángel Carracedo
[1] J. Clayton-Smith,et al. The ARID1B phenotype: What we have learned so far , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.
[2] Kathryn Roeder,et al. Most genetic risk for autism resides with common variation , 2014, Nature Genetics.
[3] Stephan J Sanders,et al. Modest Impact on Risk for Autism Spectrum Disorder of Rare Copy Number Variants at 15q11.2, Specifically Breakpoints 1 to 2 , 2014, Autism research : official journal of the International Society for Autism Research.
[4] Stephen J. Guter,et al. Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.
[5] J. Shendure,et al. A de novo convergence of autism genetics and molecular neuroscience , 2014, Trends in Neurosciences.
[6] Jianxin Shi,et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.
[7] S. Gau,et al. Deep exon resequencing of DLGAP2 as a candidate gene of autism spectrum disorders , 2013, Molecular Autism.
[8] Eric M. Morrow,et al. Using Whole-Exome Sequencing to Identify Inherited Causes of Autism , 2013, Neuron.
[9] Kathryn Roeder,et al. Rare Complete Knockouts in Humans: Population Distribution and Significant Role in Autism Spectrum Disorders , 2013, Neuron.
[10] Bradley P. Coe,et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.
[11] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[12] Y. S. Kim,et al. Global Prevalence of Autism and Other Pervasive Developmental Disorders , 2012, Autism research : official journal of the International Society for Autism Research.
[13] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[14] Michael F. Walker,et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.
[15] Elodie Ey,et al. Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders , 2012, PLoS genetics.
[16] John Wei,et al. Rare Copy Number Variation Discovery and Cross-Disorder Comparisons Identify Risk Genes for ADHD , 2011, Science Translational Medicine.
[17] S. South,et al. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants , 2011, Genetics in Medicine.
[18] J. Daniels,et al. On the complex relationship between genes and environment in the etiology of autism. , 2011, Epidemiology.
[19] Kathryn Roeder,et al. Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.
[20] Boris Yamrom,et al. Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.
[21] R. Gibbs,et al. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders , 2011, Human molecular genetics.
[22] Angelica Ronald,et al. Autism spectrum disorders and autistic traits: A decade of new twin studies , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[23] L. Pérez-Jurado,et al. Intermediate FMR1 alleles and cognitive and/or behavioural phenotypes , 2011, European Journal of Human Genetics.
[24] E. Eichler,et al. Phenotypic variability and genetic susceptibility to genomic disorders. , 2010, Human molecular genetics.
[25] Gary D Bader,et al. Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.
[26] Leslie G Biesecker,et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.
[27] Ahmed Rebai,et al. Genetic screening of two Tunisian families with generalized epilepsy with febrile seizures plus , 2009, European journal of neurology.
[28] Daniel P. Kennedy,et al. Mapping Early Brain Development in Autism , 2007, Neuron.
[29] Kenny Q. Ye,et al. Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.
[30] Matthew K Belmonte,et al. Fragile X syndrome and autism at the intersection of genetic and neural networks , 2006, Nature Neuroscience.
[31] A. Heils,et al. A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy. , 2001, American journal of human genetics.
[32] P. Jacobs,et al. FRAXA and FRAXE: the results of a five year survey , 2000, Journal of medical genetics.
[33] A. Vianna-Morgante,et al. Fully mutated and gray-zone FRAXA alleles in Brazilian mentally retarded boys. , 1999, American journal of medical genetics.
[34] C. Gillberg,et al. A Screening Questionnaire for Asperger Syndrome and Other High-Functioning Autism Spectrum Disorders in School Age Children , 1999, Journal of autism and developmental disorders.
[35] N. Ryan,et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[36] J. Bregman,et al. Diagnosing Autism: Analyses of Data from the Autism Diagnostic Interview , 1997, Journal of autism and developmental disorders.